Cardiovascular Disease

In the early phase following a kidney transplantation, inflammation is associated with increased long-term all-cause mortality, according to data published in the American Journal of Transplantation.

Adults with type 2 diabetes at high risk for cardiovascular disease add 1.7 life-years free of CVD when prescribed semaglutide along with standard diabetes care, according to study findings published in Diabetes Care.

CHICAGO — Heart disease is a leading health threat for women, according to C. Noel Bairey Merz, MD, FACC, FAHA, FESC, the director of the Barbra Streisand Women’s Heart Institute at Cedars-Sinai.

The U.S. Preventive Services Task Force has published a final recommendation that advises against the initiation of low-dose aspirin for primary CVD prevention in adults aged 60 years or older, a D-grade recommendation.

Polycystic ovary syndrome is a common endocrine disorder affecting reproductive-age women, yet the complexity and heterogeneity of PCOS have confounded researchers attempting to understand its long-term consequences.

The hyperandrogenic phenotype of polycystic ovary syndrome is the one most closely related to the things we think are “bad” for cardiovascular disease — obesity, insulin resistance — and those seem to be the driving factors of CVD risk. We also see examples of elevated CV risk in the setting of higher androgen levels in postmenopausal women and transgender men prescribed gender-affirming hormone therapy.

Adults with type 2 diabetes and cognitive impairment are more likely to experience major adverse cardiovascular events, stroke or CV mortality compared with those without cognitive impairment, according to study findings.

Combined use of an SGLT2 inhibitor and GLP-1 receptor agonist is associated with reduced odds for major adverse cardiac and cerebrovascular events and heart failure in adults with type 2 diabetes, according to study findings.

WASHINGTON — A greater number of extreme heat days was associated with elevated CV mortality in men and Black adults across the United States from 2008 to 2017, researchers reported at the American College of Cardiology Scientific Session.

Study results showed that women with breast cancer had a greater risk for CVD events, including heart failure and cardiomyopathy, than women without breast cancer.